News & Events
17 patient FIH clinical study with 1 year follow up completed – March 2022
Escala appointed Dr. Robert Auerbach as Chair of BOD – January 2022
Submitted application to FDA – December 2021
Escala was elected by a professional committee of the Israeli Innovation Authority and the WHII organizers to presnet at the Startup Pavillion during the World Congress on Women Health Innovations and Inventions (WHII) held July 9-11, 2019 at the Hilton Tel Aviv, Israel.
Escala raises nearly $1M from private investors and the Israel Innovation Authority (IIA).